If you have not already registered for Full Text Access to The Journal, then visit our registration page. |
VOLUME 70
2009
NUMBER 4
Commentary 446 Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice [PDF] Original Articles 450 Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study 458 McLean-Harvard International First-Episode Project: Two-Year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients 467 Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia: A 1-Year, Open-Label Study 477 A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients 487 A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone 500 Late-Onset Depression in Elderly Subjects From the Vienna Transdanube Aging (VITA) Study 509 Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A Multicenter, Prospective, and Naturalistic Study 518 A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia 526 Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study 540 Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study 550 A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder 562 Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial 572 A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia Focus on Alzheimer's Disease and Related Disorders 582 Commentary. Grumpy Old Men (and Women): Mere Hassle or Meaningful Clinical Evidence? [PDF] 584 Mild Behavioral Impairment and Risk of Dementia: A Prospective Cohort Study of 358 Patients Academic Highlights 593 A Roadmap to Key Pharmacologic Principles in Using Antipsychotics: Application in Clinical Practice [CME] [PDF] Letters To the Editor 601 Venlafaxine-Induced Complex Visual Hallucinations in a 17-Year-Old Boy [PDF] 603 Reliability, Not Overdiagnosis [PDF] • Reply by Mark Zimmerman, Camilo J. Ruggero, Iwona Chelminski, and Diane Young [PDF] 604 Use of Risperidone Long-Acting Injection to Support Treatment Adherence and Mood Stabilization in Pediatric Bipolar Patients: A Case Series [PDF] Book Reviews 607 The Physician as Patient: A Clinical Handbook for Mental Health Professionals [PDF] 607 Stahl’s Essential Psychopharmacology Online,revised and updated 3rd ed [PDF] 608 Patients With Substance Abuse Problems: Effective Identification, Diagnosis, and Treatment [PDF] 608 Clinical Handbook of Obsessive-Compulsive Disorder and Related Problems [PDF] Electronic CME Activities e07 Remission as the "Gold Standard" of Treatment for Depression With and Without Physical Symptoms [Abstract] e08 Efficacy of Agents in Treating Mania [Abstract] e09 Diagnostic Assessment of Major Depressive Disorder [Abstract] e10 Pain and the Brain: Chronic Widespread Pain [Abstract] |